Interface Biologics, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Interface Biologics, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Contents

• 1.1 List Of Tables
• 1.2 List of Figures
• 2 Company Overview
• 2.1 Key Information
• 2.2 Industry Outlook - Cardiovascular Devices
• 3 Major Products and Services
• 3.1 Overview
• 4 Competitors
• 5 Key Employees
• 6 Locations And Subsidiaries
• 6.1 Head Office
• 7 Recent Developments
• 7.1 Product News
  • 7.1.1 Jun 05, 2008: Interface Biologics Inc. Achieves Reductions In Platelet Adhesion Similar To Heparin Coated Devices With Use Of Non Drug Surface Additive
• 7.2 Clinical Trials
  • 7.2.1 Jun 05, 2008: Interface Biologics Inc. Achieves Reductions In Platelet Adhesion Similar To Heparin Coated Devices With Use Of Non Drug Surface Additive
• 8 Interface Biologics, Inc. Pipeline Products
• 8.1 Interface Biologics, Inc. Product Pipeline Analysis
  • 8.1.1 Interface Biologics, Inc. Pipeline Products By Equipment Type
  • 8.1.2 Interface Biologics, Inc. Pipeline Products By Development Stage
  • 8.1.3 Interface Biologics, Inc. Pipeline Products By Therapy Area
  • 8.1.4 Interface Biologics, Inc. Pipeline Products By News Summary
• 8.2 Pacemaker leads
  • 8.2.1 Product Description
  • 8.2.2 Product Status
• 8.3 Stent-grafts
  • 8.3.1 Product Description
  • 8.3.2 Product Status
• 8.4 Artificial heart valves
  • 8.4.1 Product Description
  • 8.4.2 Product Status
• 8.5 Endexo Vascular Access Catheters
  • 8.5.1 Product Description
  • 8.5.2 Product Status
  • 8.5.3 Product Milestone
  • 8.5.4 Product Patent Details
• 8.6 Bypass Grafts
  • 8.6.1 Product Description
  • 8.6.2 Product Status
• 8.7 Kinesyx Drug Eluting Stents
  • 8.7.1 Product Description
  • 8.7.2 Product Status
  • 8.7.3 Product Patent Details
• 8.8 Antimicrobial Cuffs
  • 8.8.1 Product Description
  • 8.8.2 Product Status
• 8.9 Ureteral stent
  • 8.9.1 Product Description
  • 8.9.2 Product Status
• 8.10 Epidel Peritoneal Dialysis Catheters
  • 8.10.1 Product Description
  • 8.10.2 Product Status
• 8.11 Endotracheal tubes
  • 8.11.1 Product Description
  • 8.11.2 Product Status
• 9 Appendix
• 9.1 Methodology
  • 9.1.1 Coverage
  • 9.1.2 Secondary Research
  • 9.1.3 Primary Research
  • 9.1.4 Expert Panel Validation
• 9.2 Contact Us
• 9.3 About Global Markets Direct
• 9.4 Disclaimer
• 1 List of Tables
• Table 1: Interface Biologics, Inc.,Key Facts
• Table 2: Interface Biologics, Inc., Key Employees,
• Table 3: Interface Biologics, Inc. Pipeline Products by Equipment Type
• Table 4: Interface Biologics, Inc. Pipeline Products By Development Stage
• Table 5: Interface Biologics, Inc. Pipeline Products By Therapy Area
• Table 6: Interface Biologics, Inc. Pipeline Products By News Summaries
• 1.2 List of Figures
• Figure 1: Interface Biologics, Inc. Pipeline Products By Equipment Type
• Figure 2: Interface Biologics, Inc. Pipeline Products By Equipment Type
• Figure 3: Interface Biologics, Inc. Pipeline Products By Development Stage
• Figure 4: Global Markets Direct Methodology